Portrait

Oncoscreen is an innovative company, which develops modern molecular biological protocols and offers those as diagnostic services

In the past years we have gathered longtime experience in the field of quantitative PCR and RT-PCR. Oncoscreen offers the benefit of this experience to scientific institutions in both industrial and research setting.

Oncoscreen®
Corporation for the utilisation of Molecular Biological Technology Ltd. (mbH)

Foundation year: 1998
Directors: Dr. Wolfgang Schwabe and Prof. Dr. Detlev Behnke

Material Acceptance
Specimen are accepted and processed on Monday through Friday. Please note that the analysis of quantitative gene expression studies can only be reliably performed if preparation and shipment of the specimen was consistent with our recommendations specific for the particular test. Please refer to the corresponding web page (see category, molecular diagnostics') or contact us.

Cooperations

Cooperation Society for Molecular Laboratory Diagnostics with the Clinic and General Practice of Internal Medicine/ Haematology/ Oncology, PD Dr. med. Klaus Ruffert, Ernst-Abbe-Str. 15, 07743 Jena,
University Clinic, Jena; Institute of Human Genetics and Anthropology
University Clinic Ulm; Dept. General Surgery
Cooperation agreement with Dr. Albert A. H. van Gennip and Dr. André B.P. van Kuilenburg, AMC Medical Research B.V., Amsterdam, the Netherlands

Oncoscreen®
Loebstedter Str. 93
07749 Jena
Germany

Oncoscreen®
Loebstedter Str. 93
07749 Jena
Germany
Phone: +49 (0) 3641 / 5074-0